OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington's disease
Alba Di Pardo, Giuseppe Pepe, Luca Capocci, et al.
Neurobiology of Disease (2020) Vol. 143, pp. 105009-105009
Open Access | Times Cited: 9

Showing 9 citing articles:

Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease
Mehdi Eshraghi, Pabalu P. Karunadharma, Juliana Blin, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 90

Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
Yanhong Bu, Hong Wu, Ran Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42

Implications of Sphingolipids on Aging and Age-Related Diseases
Shengxin Li, Hyun-Eui Kim
Frontiers in Aging (2022) Vol. 2
Open Access | Times Cited: 28

A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease
Johannes Burtscher, Vittorio Maglione, Alba Di Pardo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 582-582
Open Access | Times Cited: 27

Sphingolipids and impaired hypoxic stress responses in Huntington disease
Johannes Burtscher, Giuseppe Pepe, Niran Maharjan, et al.
Progress in Lipid Research (2023) Vol. 90, pp. 101224-101224
Open Access | Times Cited: 10

Metabolism in Huntington’s disease: a major contributor to pathology
Akanksha Singh, Namita Agrawal
Metabolic Brain Disease (2021) Vol. 37, Iss. 6, pp. 1757-1771
Closed Access | Times Cited: 21

Curcumin-Loaded Nanoparticles Based on Amphiphilic Hyaluronan-Conjugate Explored as Targeting Delivery System for Neurodegenerative Disorders
Giuseppe Pepe, Enrica Calce, Valentina Verdoliva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8846-8846
Open Access | Times Cited: 23

Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease
Giuseppe Pepe, Luca Capocci, Federico Marracino, et al.
Molecular Therapy (2022) Vol. 31, Iss. 1, pp. 282-299
Closed Access | Times Cited: 11

Computational insights into missense mutations in HTT gene causing Huntington’s disease and its interactome networks
Muneeza Qayyum Khan, Hira Mubeen, Zohaira Qayyum Khan, et al.
Irish Journal of Medical Science (1971 -) (2022) Vol. 192, Iss. 3, pp. 1435-1445
Closed Access | Times Cited: 4

Page 1

Scroll to top